Literature DB >> 8542898

Influence of high and low plasma insulin levels on the uptake of fluorine-18 fluorodeoxyglucose in myocardium and femoral muscle, assessed by planar imaging.

J M Huitink1, F C Visser, G R van Leeuwen, A van Lingen, J J Bax, R J Heine, G J Teule, C A Visser.   

Abstract

The aim of this study was to optimize the metabolic conditions for planar myocardial fluorine-18 fluorodeoxyglucose (FDG) imaging. The effects of high and low insulin levels during euglycaemic clamping on myocardial and femoral muscle FDG uptake were compared since insulin plays a major role in glucose metabolism. FDG uptake in 11 patients was studied using planar scintigraphy. Patients were studied twice: in the low-dose insulin protocol (LDI), insulin was infused at a rate of 20 mU/kg per hour, starting 1 h before FDG administration, while in the high-dose insulin protocol (HDI) it was infused at a rate of 100 mU/kg per hour. Glucose infusion rate was adjusted according to frequently determined blood glucose levels. Somatostatin was infused to block endogenous insulin release. Planar images were obtained from the thorax region and femoral muscles. Regions of interest were drawn over normal and abnormal myocardial areas (based on angiographic and thallium-201 data) and over lung, liver and muscle areas. After clamping, insulin levels during LDI and HDI at t = 60 were 30.6 +/- 13.3 and 129.6 +/- 30.5 mU/l respectively (P < 0.0001). Femoral muscle uptake was significantly higher during HDI (P < 0.001). Uptake in normal and abnormal myocardial areas did not differ between the two protocols. Heart/lung ratios (NS) and heart/liver ratios (P < 0.05) increased during HDI. It may be concluded that planar FDG imaging is influenced by plasma insulin levels. The euglycaemic hyperinsulinaemic clamp technique, although more demanding, gives an adjustable metabolic steady state without significantly altering the FDG uptake patterns in normal and abnormal myocardial regions. The image quality of planar FDG images improves due to lower background uptake of FDG during clamping with high plasma insulin levels.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8542898     DOI: 10.1007/bf00800596

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  34 in total

1.  Plasma insulin and glucose responses of healthy subjects to varying glucose loads during three-hour oral glucose tolerance tests.

Authors:  A Castro; J P Scott; D P Grettie; D Macfarlane; R E Bailey
Journal:  Diabetes       Date:  1970-11       Impact factor: 9.461

2.  Spatial and temporal quantitation of plane thallium myocardial images.

Authors:  D D Watson; N P Campbell; E K Read; R S Gibson; C D Teates; G A Beller
Journal:  J Nucl Med       Date:  1981-07       Impact factor: 10.057

3.  Effects of insulin on glucose metabolism in isolated heart myocytes from adult rats.

Authors:  V Chen; K H McDonough; J J Spitzer
Journal:  Biochim Biophys Acta       Date:  1985-09-30

4.  Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog.

Authors:  E J Barrett; R G Schwartz; C K Francis; B L Zaret
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

5.  A comparison of 3 methods for assessing insulin sensitivity in subjects with normal and abnormal glucose tolerance.

Authors:  R J Heine; P D Home; M Poncher; H Orskov; V Hammond; A J McCulloch; I Hanning; K G Alberti
Journal:  Diabetes Res       Date:  1985-05

6.  The effects of glucose on myocardial substrate utilization in acute myocardial infarction or angina pectoris.

Authors:  E E Martinez; J S Telles; T L Martinez; O P Portugal; R F Guimaraes; J L Herrmann; E N Lamounier; A A Caio; R C Auriemo; J A Ambrose
Journal:  Am J Cardiol       Date:  1987-11-01       Impact factor: 2.778

7.  The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers.

Authors:  J J Berry; J A Baker; K S Pieper; M W Hanson; J M Hoffman; R E Coleman
Journal:  J Nucl Med       Date:  1991-08       Impact factor: 10.057

8.  Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina.

Authors:  P Camici; L I Araujo; T Spinks; A A Lammertsma; J C Kaski; M J Shea; A P Selwyn; T Jones; A Maseri
Journal:  Circulation       Date:  1986-07       Impact factor: 29.690

9.  Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography.

Authors:  M Schwaiger; R Brunken; M Grover-McKay; J Krivokapich; J Child; J H Tillisch; M E Phelps; H R Schelbert
Journal:  J Am Coll Cardiol       Date:  1986-10       Impact factor: 24.094

Review 10.  Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography.

Authors:  P Camici; E Ferrannini; L H Opie
Journal:  Prog Cardiovasc Dis       Date:  1989 Nov-Dec       Impact factor: 8.194

View more
  3 in total

1.  Diffusely increased muscular uptake of [18F]fluorodeoxyglucose: a clue for the diagnosis of insulinoma?

Authors:  Koramadai Karuppuswamy Kamaleshwaran; Anish Bhattacharya; Dhritiman Chakraborty; Kuruva Manohar; Bhagwant Rai Mittal
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-02       Impact factor: 9.236

2.  Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia.

Authors:  Michael Gejl; Lærke Egefjord; Susanne Lerche; Kim Vang; Bo Martin Bibby; Jens Juul Holst; Annette Mengel; Niels Møller; Jørgen Rungby; Birgitte Brock; Albert Gjedde
Journal:  J Cereb Blood Flow Metab       Date:  2012-08-29       Impact factor: 6.200

3.  Application of clinical PET imaging to human laryngeal squamous cell carcinoma xenografts.

Authors:  Ou Xu; Xiaoming Li; Chunguang Shan; Xing Yang; Lin Zhang; Jingmiao Wang
Journal:  Exp Ther Med       Date:  2013-07-03       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.